ANKIT BHANDARI
Lung Cancer 1
Background information
More people die from lung cancer than from any other cancer
5-Year survival Rate is 49 Percent when confined to one part 16 percent spread within chest 2 Percent if it has spread outside of the chest
2
Risk Factors
Cigarette smoking AsbestosRadon
3
Who should be Screened?
U.S. Preventive services task force Recommends low Dose computer Tomography.
4
Two Sub Groups of Lung cancer
Small cell lung cancer Non-small cell Lung cancer
5
Clinical Features
Fever, weight loss and Hemoptysis
Chest X-ray
Lung Mass
CT Scan w/ IV contrast
6
Symptoms
Local Invasion Recurrent laryngeal nerve palsy Horner’s syndrome SVC syndrome Phrenic nerve palsy
7
SVC syndrome8
Phrenic Nerve Palsy 9
Paraneoplastic syndrome associated with lung cancers.
Syndrome Causes Likely Subtype
Cushing syndrome ACTH
Small cell carcinoma Lambert-Eaton Syndrome
Ab to voltage gated calcium channel
Hyponatermia SIADH
Hypercalcemia PTHrp Squamous cell carcinoma
Hypertrophic pulmonary osteoarthropathy
Painful periosteal growth and clubbing
Adenocarcinoma
10
Pulmonary Nodule
No symptoms, X-ray
Pulmonary Nodule
New Nodule Nodule
changed in size > 2 yr?
Stop Workup Follow Yearly
CT with thin sections through nodule
Biopsy Resect
Follow every 3 mo
Film not available
Suspicious Benign
11
Benign Versus Malignant Solitary Pulmonary nodules
Factors favor Benign diagnosis Factors that favor Malignancy
Age Less than 50 years Age more than 50 years
Non smoker Smoker or previous smoker
Size of nodule <2.0 cm Size of nodule > 3.0 cm
No Growth over 2 year period Steady growth on serial radiographs
Nodule circular and regular shaped
Nodule grossly irregular or speculated margins
Central laminated calcification Stippled or eccentric pattern
12
Pathologic Confirmation
Bronchoscopy- central CT guided percutaneous biopsy- peripheral Video Assisted thoracoscopy- inside lung
parenchymaPleural effusion is present get cytology
13
Therapy
Prognosis and management is based on tumor staging Non-small cell lung cancer
Staging Evaluation CT abdomen and a combined PET and CT scan Bone pain: bone scan and calcium and ALP levels
14
Staging and Prognosis for non-small cell Lung cancer
Stage Definition Prognosis
I Tumor surrounded by lung or pleura and 2 cm from carina
60% to 70 long term disease-free survival
II Locally advanced disease without mediastinal involvement
40% to 50% long term disease-free survival
III Mediastinal involvement, or two separate tumor nodules in same lobe without mediastinal involvement
5% to 20% long term disease-free survival
IV Metastatic Median survival 7 months
15
Treatment
NSCLC Overall Surgery is best option
Stage Treatment
I Surgery and in few cases adjuvant chemotherapy
II Surgery and adjuvant chemotherapy
III Combinations
IV Chemotherapy only
16
Therapy
SCLC Limited
Combination of Chemotherapy and Radiation therapy Widespread
Only Chemotherapy first and Radiation to decrease the incidence of brain metastases
Even if good response to Chemotherapy, response is short lived.
17
18
1) A 62-year-old man is evaluated for a persistent cough of 9 months' duration and a 4.5-kg (10-lb) unintentional weight loss over the past 6 weeks. The patient has a 30-pack-year history of smoking cigarettes and continues to smoke.
On physical examination, his vital signs are normal. His body mass index is 24. There are decreased breath sounds and dullness to percussion at the right base. The remainder of the physical examination is normal.
Chest radiography confirms a right pleural effusion. Chest computed tomography (CT) confirms a right pleural effusion and a 2.1-cm spiculated nodule in the right middle lobe.
Which of the following is the most appropriate next Diagnostic Test? A. CT-Guided biopsy of the lung nodule B. Integrated Whole body PET-CT scan C. Magnetic resonance imaging of the brain D. Radiographic bone survey E. Thoracentesis and pleural fluid cytology
19
2) A 65-year-old woman seeks consultation in the office regarding lung cancer screening. She has a 40-pack-year history of cigarette smoking and continues to smoke. Her only active medical problem is chronic obstructive pulmonary disease treated with daily tiotropium inhaler and an albuterol inhaler as needed.
On physical examination, her vital signs are normal. Breath sounds are distant with occasional wheezing. The remainder of the physical examination is normal.
Which of the following screening tests can be recommended? A. Annual Chest radiography B. Annual Sputum for cytology C. Combination annual chest radiography and sputum for cytology D. Low-dose spiral chest computed tomography
20
3) A 62-year-old man is evaluated following the incidental discovery of a 3-mm left lower lobe lung nodule on a recent computed tomography (CT) scan of the abdomen performed to evaluate for kidney stones. He has never smoked and has an otherwise unremarkable medical history. He takes no medications.
On physical examination, his vital signs are normal. The physical examination is unremarkable.
A dedicated CT of the chest shows only the 3-mm left lower lobe nodule and is otherwise normal. There are no other chest images available for comparison.
Which of the following is the most appropriate next step in management of this patient?
A. CT of the chest in 3 months B. CT of the chest in 6 months C. CT of the chest in 12 months D. No follow-up imaging
21
4) A 55-year-old woman is evaluated for a cough, weakness, and fatigue of 4 weeks' duration. She has a 40-pack-year history of cigarette smoking.
On physical examination, her temperature is normal, blood pressure is 136/78 mm Hg, and pulse rate is 68 beats/min. No palpable lymphadenopathy is noted. The cardiopulmonary and neurologic examinations are normal.
A chest radiograph demonstrates a 5-cm left upper lobe pulmonary mass. A subsequent computed tomography (CT) scan shows the mass but no evident mediastinal lymphadenopathy. A positron emission tomography (PET) scan displays radiographic uptake in the mass but no disease elsewhere. A CT-guided biopsy demonstrates squamous cell carcinoma.
Which of the following is the most appropriate treatment? A. Combination chemotherapy and radiation B. Radiation C. Surgery and adjuvant chemotherapy D. Systemic chemotherapy
22